Shares of Tevogen Bio Holdings Inc. (NASDAQ:TVGNW – Get Free Report) crossed below its fifty day moving average during trading on Monday. The stock has a fifty day moving average of $0.06 and traded as low as $0.0523. Tevogen Bio shares last traded at $0.0559, with a volume of 761,799 shares traded.
Tevogen Bio Stock Down 34.0%
The stock’s 50 day moving average price is $0.06 and its 200 day moving average price is $0.05.
About Tevogen Bio
Tevogen Bio is a clinical-stage biotechnology company developing precision T-cell therapies. Its approach uses selected donor-derived T cells designed to recognize specific targets, with the goal of developing treatments for cancer and infectious diseases.
The company’s pipeline includes investigational cell therapy candidates, including programs directed at viral targets. Tevogen also describes its ExacTcell platform as supporting the identification and development of targeted T-cell therapies.
Featured Articles
- Five stocks we like better than Tevogen Bio
- Wall Street May Be Making a Big Mistake With monday.com Stock
- Are These 2 Mid-Cap Growth Stocks Worth the Risk?
- Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?
- Cloudflare’s 20% Sell-Off May Have Created an Opening for Investors
Receive News & Ratings for Tevogen Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tevogen Bio and related companies with MarketBeat.com's FREE daily email newsletter.
